Achillefs Ntranos, MD
- ASSISTANT PROFESSOR | Neurology, Multiple Sclerosis
Specialty:
NeurologyResearch Topics:
Epigenetics, Genomics, Immunology, Metabolomics, Multiple Sclerosis, Personalized Medicine, T Cells, Translational ResearchAchillefs Ntranos, MD, is an Assistant Professor of Neurology at the Icahn School of Medicine at Mount Sinai and the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, specializing in multiple sclerorsis and demyelinating diseases. He sees patients at Mount Sinai Union Square.
Dr. Ntranos has conducted high-impact translational research in multiple sclerosis and neuroimmunology at Johns Hopkins and Mount Sinai, which he strives to integrate in his clinical practice to provide exceptional evidence-based patient care. His research has increased our understanding of how medications work in multiple sclerosis, which could help us personalize our treatment approach in the future. Apart from seeing patients, Dr. Ntranos is leading a translational research laboratory at Mount Sinai, where he continues to conduct innovative research on the cause of multiple sclerosis and how we can best stop inflammatory activity and progression of disease in each individual patient.
Dr. Ntranos received his medical degree from the National and Kapodistrian University of Athens Medical School in Greece, after which he joined Johns Hopkins University in Baltimore, Maryland, for his research fellowship in neuroimmunology. His work at Johns Hopkins revealed a new mechanism by which fingolimod was affecting the immune system and was awarded the Whitaker Prize for Multiple Sclerosis Research by the Foundation of the Consortium of Multiple Sclerosis Centers in 2013. During that time, he also contributed to the pilot trial of vitamin D supplementation in patients with multiple sclerosis to investigate its effect on the immune system, which was published in Neurology. After his internship in internal medicine at Albert Einstein School of Medicine, Dr. Ntranos joined the Icahn School of Medicine at Mount Sinai for his residency training in neurology, where he was nominated Chief Resident during his final year of the program. He then completed his fellowship in multiple sclerosis and demyelinating diseases at Mount Sinai, for which he received a research education grant from the National Institute of Neurological Diseases and Stroke and was awarded the Leon Levy Fellowship in Neurosciences.
Dr. Ntranos' work during his fellowship had a great impact on changing the view about how dimethyl-fumarate works in multiple sclerosis patients and highlighted that metabolites, such as dimethyl-fumarate, could modulate the immune system by altering the way the genetic code is being read via epigenetic mechanisms. This work was published on the cover and Editor's choice section of Brain, one of the top clinical neurology journals. While trying to translate his research findings to advance clinical practice, Dr. Ntranos proposed that the immunologic response to dimethyl-fumarate in the blood of individual patients could predict who is going to respond and who is not going to respond to the treatment in the future. These findings, which could help personalize our treatment approach in the future, were presented at two major scientific meetings, the American Academy of Neurology and the Americas Committee for Treatment and Research in Multiple Sclerosis in 2019.
Certifications
Neurology, American Board of Psychiatry and Neurology
Clinical Focus
- Multiple Sclerosis
- Neuromyelitis Optica
Education
MD, University of Athens Medical School
Internship, Internal Medicine, Albert Einstein School of Medicine
Residency, Neurology, Icahn School of Medicine at Mount Sinai
Fellowship, Multiple Sclerosis and Demyelinating diseases, Icahn School of Medicine at Mount Sinai
-
2017
Leon Levy Fellowship in Neurosciences -
2016
R25 Research Education Grant -
2016
Chief Resident in Neurology -
2013
Whitaker Prize for Multiple Sclerosis Research -
2011
Lambrakis Award in Pharmacology Research -
2008
Medical Education Scholarship
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Ntranos did not report having any of the following types of financial relationships with industry during 2019 and/or 2020: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.